公开(公告)号：NO20032926A

公开(公告)日：2003-08-25

申请号：NO20032926

申请日：2003-06-25

Applicant: REDDYS LAB LTD DR

Inventor： NATESAN SELVAKUMAR ,  DAS JAGATTARAN ,  IQBAL JAVED ,  MAGADI SITARAM KUMAR ,  MAMIDI NAGA VENKATA SRINIVASA ,  RAMANUJAM RAJAGOPALAN ,  SUNDARABABU BASKARAN ,  LOHRAY BRAJ BHUSHAN

IPC: A61K31/422 ,  A61K31/423 ,  A61P31/04 ,  C07D263/20 ,  C07D263/22 ,  C07D263/24 ,  C07D263/58 ,  C07D413/08 ,  C07D413/10 ,  C07D413/14 ,  C07D417/08 ,  C07D417/10

CPC classification number: C07D263/20 ,  C07D263/22 ,  C07D263/24 ,  C07D413/10 ,  C07D413/14 ,  C07D417/10

公开(公告)号：NO20080629A

公开(公告)日：2008-02-19

申请号：NO20080629

申请日：2008-02-04

Applicant: REDDYS LAB LTD DR

Inventor： POTLURI VIJAY KUMAR ,  DAS SAIBAL KUMAR ,  SASMAL PRADIP KUMAR ,  IQBAL JAVED ,  MISRA PARIMAL ,  CHAKRABARTI RANJAN ,  TALWAR RASHMI

IPC: C07D277/14

CPC classification number: C07D277/42

公开(公告)号：EA008947B1

公开(公告)日：2007-10-26

申请号：EA200400762

申请日：2002-12-02

Applicant: REDDYS LAB LTD DR

Inventor： BHUNIYA DEBNATH ,  DAS SAIBAL KUMAR ,  MADHAVAN GURRAM RANGA ,  IQBAL JAVED ,  CHAKRABARTI RANJAN ,  VIKRAMADITHYAN REEBA KANNIMEL

IPC: A61K45/00 ,  C07C309/66 ,  A61K31/145 ,  A61K31/167 ,  A61K31/216 ,  A61K31/255 ,  A61K31/27 ,  A61K31/353 ,  A61K31/4439 ,  A61K31/454 ,  A61K31/4709 ,  A61K31/496 ,  A61K31/5377 ,  A61K31/541 ,  A61P1/04 ,  A61P1/18 ,  A61P3/04 ,  A61P3/06 ,  A61P3/10 ,  A61P9/00 ,  A61P9/10 ,  A61P9/12 ,  A61P13/12 ,  A61P15/08 ,  A61P17/06 ,  A61P19/10 ,  A61P21/04 ,  A61P25/28 ,  A61P27/02 ,  A61P29/00 ,  A61P35/00 ,  C07C279/14 ,  C07C303/30 ,  C07C309/73 ,  C07C311/53 ,  C07C311/55

Abstract: Изобретениеотноситсяк антидиабетическим, гиполипидемическим, гипохолестеринемическимсредствами средствампротивожирения, представленнымсоединениями, являющимисяпреимущественноагонистами PPARα, ихтаутомернымиформами, стереоизомерами, ихполиморфами, ихфармацевтическиприемлемымисолями, ихфармацевтическиприемлемымисольватамии содержащимиихфармацевтическиприемлемымикомпозициями. Изобретениетакжекасаетсяспособовполученияи примененияэтихсоединенийв качествеантидиабетических, гиполипидемических, гипохолестеринемическихсоединенийи средствпротивожирения.

公开(公告)号：CO5580819A2

公开(公告)日：2005-11-30

申请号：CO04035096

申请日：2004-04-16

Applicant: REDDYS LAB LTD DR

Inventor： BHUNIYA DEBNATH ,  SAIBAL KUMAR DAS ,  MADHAVAN GURRAM RANGA ,  IQBAL JAVED ,  CHAKRABARTI RANJAN ,  CHANDER MOHAN ,  MOHAN SANKAR

IPC: C07C229/34 ,  A61K31/538 ,  A61K31/5415 ,  A61P3/06 ,  A61P3/10 ,  C07C229/42 ,  C07D265/36 ,  C07D279/16

Abstract: 1.- Nuevos compuestos caracterizados porque son de la fórmula (I)sus derivados, sus análogos, sus formas tautoméricas, sus estereoisómeros, sus sales, sus solvatos, en donde W representa NR12, R12 representa hidrógeno, R10 y R11 pueden ser los mismos o diferentes y representan hidrógeno o un grupo substituido o insubstituido seleccionado del grupo alquilo, alcoxi, arilo o aralquilo; Ar representa un grupo aromático o heterocíclico substituido o insubstituido divalente único o fusionado; R5 representa un átomo de hidrógeno, hidroxi, alcoxi, halógeno, alquilo, un grupo aralquilo substituido o insubstituido o forma un enlace junto con el grupo R6 adyacente; R6 representa hidrógeno, hidroxi, alcoxi, halógeno, un grupo alquilo inferior, acilo, aralquilo substituido o insubstituido o R6 forma un enlace junto con R5; R7 puede ser hidrógeno o grupos substituidos o insubstituidos seleccionados de grupos alquilo, cicloalquilo, arilo, aralquilo, alcoxialquilo, alcoxicarbonilo, ariloxicarbonilo, alquilaminocarbonilo, arilaminocarbonilo, acilo, heterociclilo, heteroarilo, heteroaralquilo; R8 puede ser hidrógeno o grupos substituidos o insubstituidos seleccionados de grupos alquilo, cicloalquilo, arilo, aralquilo, heterociclilo, heteroarilo o heteroaralquilo; Y representa oxígeno, azufre o NR13, en donde R13 representa hidrógeno o grupos substituidos o insubstituidos seleccionados de grupos alquilo, arilo, hidroxialquilo, aralquilo, heterociclilo, heteroarilo, o heteroaralquilo; R8 y R13 juntos pueden formar una estructura cíclica de 5 ó 6 elementos substituida o insubstituida, que contiene átomos de carbono, los cuales pueden opcionalmente contener uno o más heteroátomos seleccionados de oxígeno, azufre o nitrógeno; m es un entero que varían de 0-6.

公开(公告)号：HU0402550A2

公开(公告)日：2005-07-28

申请号：HU0402550

申请日：2002-12-02

Applicant: REDDYS LAB LTD DR

Inventor： BHUNIYA DEBNATH ,  DAS SAIBAL KUMAR ,  MADHAVAN GURRAM RANGA ,  IQBAL JAVED ,  CHAKRABARTI RANJAN ,  VIKRAMADITHYAN REEBA KANNIMEL

IPC: A61K45/00 ,  A61K31/216 ,  A61K31/255 ,  A61K31/353 ,  A61K31/4439 ,  A61K31/454 ,  A61K31/4709 ,  A61K31/496 ,  A61K31/5377 ,  A61K31/541 ,  A61P1/04 ,  A61P1/18 ,  A61P3/04 ,  A61P3/06 ,  A61P3/10 ,  A61P9/00 ,  A61P9/10 ,  A61P9/12 ,  A61P13/12 ,  A61P15/08 ,  A61P17/06 ,  A61P19/10 ,  A61P21/04 ,  A61P25/28 ,  A61P27/02 ,  A61P29/00 ,  A61P35/00 ,  C07C279/14 ,  C07C303/30 ,  C07C309/66 ,  C07C309/73 ,  C07C311/53

Abstract: The present invention relates to novel antidiabetic, hypolipidemic, antiobesity and hypocholesterolemic compounds of formula (I), their derivatives, their analogs, their tautomeric forms, their stereoisomers, their polymorphs, their pharmaceutically acceptable salts, their pharmaceutically acceptable solvates and pharmaceutically acceptable compositions containing them.

公开(公告)号：HRP20030522A2

公开(公告)日：2005-06-30

申请号：HRP20030522

申请日：2003-06-26

Applicant: REDDYS LAB LTD DR

Inventor： DAS JAGATTARAN ,  NATESAN SELVAKUMAR ,  IQBAL JAVED ,  MAGADI SITARAM KUMAR ,  MAMIDI NAGA VENKATA SRINIVASA ,  RAMANUJAM RAJAGOPALAN ,  SUNDARABABU BASKARAN ,  LOHRAY BRAJ BHUSHAN

IPC: A61K31/422 ,  A61K31/423 ,  A61P31/04 ,  C07D263/20 ,  C07D263/22 ,  C07D263/24 ,  C07D263/58 ,  C07D413/08 ,  C07D413/10 ,  C07D413/14 ,  C07D417/08 ,  C07D417/10 ,  C07D263/10 ,  C07D413/12 ,  C07D417/12 ,  A61K31/42

Abstract: The present invention relates to novel oxazolidinone compounds of the general formula (I). where R 1 , R 2 , R 3 , Y 1 , Y 2 , Y 3 , and Z are as defined in the description; their derivatives, their analogs, their tautomeric forms, their stereoisomers, their polymorphs, their pharmaceutically acceptable salts, their pharmaceutically acceptable solvates and pharmaceutical compositions containing them.

公开(公告)号：NO20041998L

公开(公告)日：2004-07-02

申请号：NO20041998

申请日：2004-05-14

Applicant: REDDYS LAB LTD DR

Inventor： CHAKRABARTI RANJAN ,  IQBAL JAVED ,  BHUNIVA DEBNATH ,  DAS SAIBAL KUMAR ,  MADHAVAN GURRAM RANGA

IPC: A61K9/08 ,  A61K9/10 ,  A61K9/14 ,  A61K9/20 ,  A61K9/48 ,  A61K31/538 ,  A61K31/5415 ,  A61P1/04 ,  A61P1/14 ,  A61P1/18 ,  A61P3/04 ,  A61P3/06 ,  A61P3/10 ,  A61P9/10 ,  A61P9/12 ,  A61P13/12 ,  A61P15/00 ,  A61P17/06 ,  A61P19/10 ,  A61P21/04 ,  A61P25/28 ,  A61P29/00 ,  A61P35/00 ,  A61P43/00 ,  C07B61/00 ,  C07C227/04 ,  C07C227/18 ,  C07C229/34 ,  C07C229/42 ,  C07D265/36 ,  C07D279/16

Abstract: The present invention relates to novel propionic acid derivatives. More particularly, the present invention relates to beta-phenyl alpha-oxysubstituted propionic acids of the general formula (I). The present invention also relates to processes for the preparation of compounds of the formula (I) and their use in the preparation of compounds of formula (II).

公开(公告)号：HU0302580A2

公开(公告)日：2003-11-28

申请号：HU0302580

申请日：2001-12-26

Applicant: REDDYS LAB LTD DR

Inventor： DAS JAGATTARAN ,  IQBAL JAVED ,  LOHRAY BRAJ BHUSHAN ,  MAGADI SITARAM KUMAR ,  MAMIDI NAGA VENKATA SRINIVASA ,  NATESAN SELVAKUMAR ,  RAMANUJAM RAJAGOPALAN ,  SUNDARABABU BASKARAN

IPC: A61K31/422 ,  A61K31/423 ,  A61P31/04 ,  C07D263/20 ,  C07D263/22 ,  C07D263/24 ,  C07D263/58 ,  C07D413/08 ,  C07D413/10 ,  C07D413/14 ,  C07D417/08 ,  C07D417/10

Abstract: The present invention relates to novel oxazolidinone compounds of the general formula (I). where R 1 , R 2 , R 3 , Y 1 , Y 2 , Y 3 , and Z are as defined in the description; their derivatives, their analogs, their tautomeric forms, their stereoisomers, their polymorphs, their pharmaceutically acceptable salts, their pharmaceutically acceptable solvates and pharmaceutical compositions containing them.

公开(公告)号：AU2002348829A1

公开(公告)日：2003-07-09

申请号：AU2002348829

申请日：2002-12-17

Applicant: REDDYS LAB LTD DR

Inventor： CHAKRABARTI RANJAN ,  DAS SAIBAL KUMAR ,  BHUNIYA DEBNATH ,  MADHAVAN GURRAM RANGA ,  IQBAL JAVED

IPC: A61K31/395 ,  A61K31/519 ,  A61P3/06 ,  A61P3/10 ,  A61P9/10 ,  A61P19/10 ,  A61P29/02 ,  A61P35/00 ,  C07D231/40 ,  C07D473/00 ,  C07D487/04

Abstract: The present invention relates to novel antidiabetic, hypolipidemic, antiobesity and hypocholesterolemic compounds, their derivatives, their analogs, their tautomeric forms, their stereoisomers, their polymorphs, their pharmaceutically acceptable salts, their pharmaceutically acceptable solvates and pharmaceutically acceptable compositions containing them. More particularly, the present invention relates to novel alkyl carboxylic acids of the general formula (I), their derivatives, their analogs, their tautomeric forms, their stereoisomers, their polymorphs, their pharmaceutically acceptable salts, their pharmaceutically acceptable solvates and pharmaceutically acceptable compositions containing them.

公开(公告)号：CA2463685A1

公开(公告)日：2003-04-24

申请号：CA2463685

申请日：2002-10-15

Applicant: REDDYS LAB LTD DR

Inventor： DAS SAIBAL KUMAR ,  MADHAVAN GURRAM RANGA ,  BHUNIYA DEBNATH ,  CHAKRABARTI RANJAN ,  IQBAL JAVED ,  CHANDER MOHAN ,  MOHAN SANKAR

IPC: A61K9/08 ,  A61K9/10 ,  A61K9/14 ,  A61K9/20 ,  A61K9/48 ,  A61K31/538 ,  A61K31/5415 ,  A61P1/04 ,  A61P1/14 ,  A61P1/18 ,  A61P3/04 ,  A61P3/06 ,  A61P3/10 ,  A61P9/10 ,  A61P9/12 ,  A61P13/12 ,  A61P15/00 ,  A61P17/06 ,  A61P19/10 ,  A61P21/04 ,  A61P25/28 ,  A61P29/00 ,  A61P35/00 ,  A61P43/00 ,  C07B61/00 ,  C07C227/04 ,  C07C227/18 ,  C07C229/34 ,  C07C229/42 ,  C07D265/36 ,  C07D279/16

Abstract: The present invention relates to novel propionic acid derivatives. More particularly, the present invention relates to beta-phenyl alpha- oxysubstituted propionic acids of the general formula (I). The present invention also relates to processes for the preparation of compounds of the formula (I) and their use in the preparation of compounds of formula (II).